Cogprints

In Vitro protective effect of Vitamin B12 derivatives against thimerosal-induced oxidative stress in human cultured neuronal cells, SH-SY5Y

Mostafa I. Waly, Amanat Ali, Mohamed M. Essa (2010) In Vitro protective effect of Vitamin B12 derivatives against thimerosal-induced oxidative stress in human cultured neuronal cells, SH-SY5Y. [Journal (Paginated)]

Full text available as:

[img]PDF (In Vitro protective effect of Vitamin B12 derivatives against thimerosal-induced oxidative stress in human cultured neuronal cells, SH-SY5Y) - Published Version
Available under License Creative Commons Attribution No Derivatives.

873Kb

Abstract

This study is directed towards investigating the ability of various forms of vitamin B12 to augment intracellular gluthathione (GSH) level as well as studying their possible protective effect against the thimerosal-inuced oxidative stress. SH-SY5Y human neuroblastoma cell culture system was used as a model for this study. Cells were acutely (60 minutes) treated with 3 different vitamin B12 derivatives (methyl-, hydroxy- and cyanocobalamin) in the presence and absence of thimerosal, vaccine antimicrobial agent. The results revealed that only methylcobalamin augmented the GSH level, as compared to other forms (hydrorxy- and cyanocobalamin). Also methylcobalamin was the only derivative that showed a protective effect against the thimerosal-induced depletion of GSH. Our findings provide evidence that thimerosal induces oxidative stress in human neuronal cells by depleting GSH and only methylcobalamin protects the cells against such insult and therfore improving the antioxidant intracellular capacity against oxidative stress, a common cause for the pathogenesis of many diseases including, autism.

Item Type:Journal (Paginated)
Keywords:Vitamin B12 derivatives, thimerosal, glutathione, folate, autism
Subjects:JOURNALS
ID Code:7079
Deposited By:International Journal of Biological and Medical Research , (IJBMR) ISSN:0976-6685
Deposited On:26 Oct 2010 19:13
Last Modified:11 Mar 2011 08:57

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

[1] Leclerc D, Odièvre M, Wu Q, Wilson A, Huizenga JJ, Rozen R, Scherer SW, Gravel RA. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. Gene. 1999; 240:75-88.

[2] Kang SS, Wong PW, Norusins M. Homocysteinemia due to folate deficiency. Metabolism. 1987; 36:458-462.

[3] Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990; 76:871-881.

[4] Joosten E, van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, Allen RH. Metabolic evidence that deficiencies of vitamin B12 (cobalamin), folate and vitamin B6 occur commonly in elderly people. Am J Clin Nutr. 1993; 58:468-476.

[5] Stampfer MJ, Willett WC. Homocysteine and marginal vitamin deficiency:The importance of adequate vitamin intake. JAMA. 1993; 270:2726-2727.

[6] Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: A study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther. 1989; 46:510-520.

[7] Mckeeser MP, Weri DG, Mollony A, Scott JM. Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clinical Science. 1991; 81:551-556.

[8] Weissback H, Dickerman H. Biochemical role of vitamin B12. Physiol Review. 1965; 45:80-98.

[9] Jacob RA. Folate, DNA methylation and gene expression: factors of nature and nurture. Am J Clin Nutr. 2000; 72:903-904.

[10] Wainfan E, Poirier LA. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 1992; 52:2071S-2077S.

[11] Keshet I, Yisraeli J, Cedar H. Effect of regional DNA methylation on gene expression. Proc Natl Acad Sci USA. 1985; 82:2560-2564.

[12] Kass SU, Landsberger N, Wolffe AP. DNA methylation directs a time-dependent repression of transcription initiation. Curr Biol. 1997; 7:157-165.

[13] Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-2698.

[14] Stehouner CD. Heterogeneity of the association between plasma hmocysteine and atherothrombotic disease: insights from studies of vascular structure and function. Clin Chem Lab Med. 2001; 39:705-709.

[15] Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274:1049-1057.

[16] Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002; 346:476-483.

[17] Brennt CE, Smith JR. The inhibitory effects of nitrous oxide and methylmercury in vivo on methionine synthase (EC 2.1.1.13) activity in the brain, liver, ovary and spinal cord of the rat. Gen Pharmacol 1989; 20:427-431.

[18] Frasca V, Riazzi B, Matthews RG. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem. 2001; 276:27296-27303.

[19] Koblin DD and Tomerson BW. methionine synthase activity in mice following acute exposure to ethanol and nitrous oxide. Biochem Pharmacol. 1989; 38:1353-1358.

[20] Stabler SP, Brass EP, Marcell PD, Allen RH. Inhibition of cobalamin dependent enzymes by cobalamin analogues in rats. J Clin Invest 1991; 87:1422-1430.

[21] Matthews JH. Cyanocobalamin [c-lactan] inhibits vitamin B12 and causes cytotoxicity in HL60 cells: methionine protects cells completely. Blood. 1997; 89:4600-4607.

[22] Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Charnitsky VA, Deth RC. Activation of methionine synthase by insulin like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mole Psychiatry. 2004; 9(4): 358-370.

[23] Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Medical Hypothesis. 2001; 56:462-471.

[24] Bernard S, Enayati. The role of mercury in the pathogenesis of autism. Mol Psychiatry. 2001; 7:S42-S43.

[25] Piyasirisilp S, Henachndha T. Neurological adverse events associated with vaccination. Curr Opin Neurol. 2002; 15:333-338.

[26] Lowry OH, Rosebrough NJ, Fait AL, Ramdal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193:265-275.

[27] Banerjee R, Chen Z, Gulati S. Methionine synthase from pig liver. Methods enzymol. 1997; 281:189-196.

[28] Banerjee RV, Matthews RG. Cobalamin dependent methionine synthase. FASEB. 1990; 4:1450-1459.

[29] Oltean S, Banerjee R. Nutritional modulation of gene expression and homocysteine modulation by vitamin B12. J Biol Chem. 2003; 278:20778-20784.

[30] Masashi K, Satoshi K, Yoshihito H, Yutaka T, Kastuyuki K, Akinori A. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Investigative ophthalmology & visual Science. 1997; 38(5): 848-854.

[31] James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009; 89(1): 425-430.

Metadata

Repository Staff Only: item control page